Li, Heng <br/><br/>
ROCK inhibitor abolishes the antibody response in experimental autoimmune myasthenia gravis.  [electronic resource] 

 -  Molecular and cellular neurosciences  07 2016 
 - 106-13 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-9327 
<br/><br/><label>Standard No.: </label>10.1016/j.mcn.2016.05.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine--analogs & derivatives<br/>Animals<br/>Autoimmunity--drug effects<br/>B-Lymphocytes--drug effects<br/>Female<br/>Germinal Center--cytology<br/>Myasthenia Gravis, Autoimmune, Experimental--therapy<br/>Protein Kinase Inhibitors--pharmacology<br/>Rats<br/>Rats, Inbred Lew<br/>T-Lymphocytes, Helper-Inducer--drug effects<br/>rho-Associated Kinases--antagonists & inhibitors